CHD
40
3
BEN
53
3
AMAT
46
-4
BIIB
48
2
DE
46
-3
AES
49
-2
BRK.B
47
4
ADBE
56
4
VIX
46
13
DAL
70
-2
CMCSA
55
2
AMG
71
-3
COF
65
-2
ADI
70
-6
CCI
36
3
AIZ
76
13
EOG
46
14
AZO
40
-3
D
48
3
DRI
61
5
CHD
40
3
BEN
53
3
AMAT
46
-4
BIIB
48
2
DE
46
-3
AES
49
-2
BRK.B
47
4
ADBE
56
4
VIX
46
13
DAL
70
-2
CMCSA
55
2
AMG
71
-3
COF
65
-2
ADI
70
-6
CCI
36
3
AIZ
76
13
EOG
46
14
AZO
40
-3
D
48
3
DRI
61
5
Financhill
Back

KraneShares Emerging Markets Consumer Tech Idx ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Buy
54

KEMQ
KraneShares Emerging Markets Consumer Tech Idx ETF

Last Price:
$25.25
Seasonality Move:
-0.05%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$54.77
Seasonality Move:
14.46%
Buy
54
KraneShares Emerging Markets Consumer Tech Idx ETF (KEMQ) is a Buy

Is KraneShares Emerging Markets Consumer Tech Idx ETF a Buy, Sell or Hold?

  • The current KraneShares Emerging Markets Consumer Tech Idx ETF [KEMQ] share price is $24.91. The Score for KEMQ is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • KEMQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $54.74. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KEMQ Stock Price Chart

What is KraneShares Emerging Markets Consumer Tech Idx ETF's stock price today?

  • The KraneShares Emerging Markets Consumer Tech Idx ETF share price today is $24.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KEMQ is experiencing selling pressure, which indicates risk of future bearish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $54.74
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.

KEMQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.22 Sell
Relative Strength Index (14 RSI): 35.88 Sell
Chaikin Money Flow: -3907 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.25 - 26.21) Sell
Bollinger Bands (100): (23.74 - 26.76) Sell

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 45.45 Sell
Chaikin Money Flow: -1078798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.55 - 56.85) Buy
Bollinger Bands (100): (52.52 - 65.44) Sell

KEMQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.58 Sell
20-day SMA: 25.57 Sell
50-day SMA: 26.12 Sell
200-day SMA: 22.72 Buy
8-day EMA: 25.41 Sell
20-day EMA: 25.67 Sell
50-day EMA: 25.34 Sell
200-day EMA: 16.04 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.72 Sell
20-day SMA: 54.52 Buy
50-day SMA: 59.78 Sell
200-day SMA: 50.98 Buy
8-day EMA: 56.04 Sell
20-day EMA: 55.88 Sell
50-day EMA: 56.44 Sell
200-day EMA: 37.2 Buy

KraneShares Emerging Markets Consumer Tech Idx ETF Earnings Growth & KEMQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

KraneShares Emerging Markets Consumer Tech Idx ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):